Found: 203
Select item for more details and to access through your institution.
Pulmonary Tumor Thrombotic Microangiopathy Appearance on Dual-Energy Computed Tomography.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I study of TAS-121, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, in patients with non-small-cell lung cancer harboring EGFR mutations.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 6, p. 1207, doi. 10.1007/s10637-019-00732-4
- By:
- Publication type:
- Article
Safety, tolerability, and pharmacokinetic profile of dabrafenib in Japanese patients with BRAF<sup>V600</sup> mutation-positive solid tumors: a phase 1 study.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 2, p. 259, doi. 10.1007/s10637-017-0502-8
- By:
- Publication type:
- Article
Phase I study of Nivolumab, an anti-PD-1 antibody, in patients with malignant solid tumors.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 207, doi. 10.1007/s10637-016-0411-2
- By:
- Publication type:
- Article
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
- Published in:
- Investigational New Drugs, 2017, v. 35, n. 2, p. 217, doi. 10.1007/s10637-017-0435-2
- By:
- Publication type:
- Article
Phase I trial of volasertib, a Polo-like kinase inhibitor, in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2016, v. 34, n. 1, p. 66, doi. 10.1007/s10637-015-0300-0
- By:
- Publication type:
- Article
Phase I study of ipilimumab in phased combination with paclitaxel and carboplatin in Japanese patients with non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 4, p. 881, doi. 10.1007/s10637-015-0243-5
- By:
- Publication type:
- Article
Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 641, doi. 10.1007/s10637-015-0229-3
- By:
- Publication type:
- Article
Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 3, p. 632, doi. 10.1007/s10637-015-0227-5
- By:
- Publication type:
- Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
- By:
- Publication type:
- Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Erratum to: Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- 2013
- By:
- Publication type:
- Correction notice
Safety and tolerability of AZD8055 in Japanese patients with advanced solid tumors; a dose-finding phase I study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 677, doi. 10.1007/s10637-012-9860-4
- By:
- Publication type:
- Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1548, doi. 10.1007/s10637-011-9715-4
- By:
- Publication type:
- Article
Efficacy of RAD001 (everolimus) against advanced gastric cancer with peritoneal dissemination.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 6, p. 1198, doi. 10.1007/s10637-010-9464-9
- By:
- Publication type:
- Article
Pemetrexed Continuation Maintenance in Patients with Nonsquamous Non-small Cell Lung Cancer: Review of Two East Asian Trials in Reference to PARAMOUNT.
- Published in:
- Cancer Research & Treatment, 2015, v. 47, n. 3, p. 424, doi. 10.4143/crt.2013.266
- By:
- Publication type:
- Article
Synergistic interaction between the EGFR tyrosine kinase inhibitor gefitinib (Iressa) and the DNA topoisomerase I inhibitor CPT-11 (irinotecan) in human colorectal cancer cells.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 3, p. 464, doi. 10.1002/ijc.11539
- By:
- Publication type:
- Article
Molecular determinants of UCN-01-induced growth inhibition in human lung cancer cells.
- Published in:
- International Journal of Cancer, 2000, v. 85, n. 2, p. 275, doi. 10.1002/(SICI)1097-0215(20000115)85:2<275::AID-IJC20>3.0.CO;2-5
- By:
- Publication type:
- Article
Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202.
- Published in:
- Radiation Oncology, 2009, v. 4, p. 1, doi. 10.1186/1748-717X-4-16
- By:
- Publication type:
- Article
Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 179, doi. 10.1016/j.clpt.2006.04.012
- By:
- Publication type:
- Article
The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung Cancer.
- Published in:
- Molecular Therapy, 2015, v. 23, n. 4, p. 717, doi. 10.1038/mt.2015.10
- By:
- Publication type:
- Article
Exploratory Analysis Comparing Fosnetupitant Versus Fosaprepitant for Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting (CINV): A Randomized, Double-Blind, Phase 3 Study (CONSOLE).
- Published in:
- Oncology & Therapy, 2022, v. 10, n. 1, p. 253, doi. 10.1007/s40487-022-00188-2
- By:
- Publication type:
- Article
Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.
- Published in:
- Carcinogenesis, 2002, v. 23, n. 7, p. 1177, doi. 10.1093/carcin/23.7.1177
- By:
- Publication type:
- Article
Pharmacokinetic Properties of nab-Paclitaxel in Asian Patients with Advanced Solid Tumors.
- Published in:
- Asia Pacific Journal of Oncology & Hematology, 2009, v. 1, n. 2, p. 51
- By:
- Publication type:
- Article
Phase I Study of Paclitaxel by Three-hour Infusion: Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities.
- Published in:
- Cancer Science, 1995, v. 86, n. 12, p. 1203, doi. 10.1111/j.1349-7006.1995.tb03316.x
- By:
- Publication type:
- Article
Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions.
- Published in:
- Cancer Science, 1995, v. 86, n. 12, p. 1198, doi. 10.1111/j.1349-7006.1995.tb03315.x
- By:
- Publication type:
- Article
A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38.
- Published in:
- Cancer Science, 1995, v. 86, n. 1, p. 101, doi. 10.1111/j.1349-7006.1995.tb02994.x
- By:
- Publication type:
- Article
A Randomized Cross-over Study of High-dose Metoclopramide plus Dexamethasone versus Granisetron plus Dexamethasone in Patients Receiving Chemotherapy with High-dose Cisplatin.
- Published in:
- Cancer Science, 1994, v. 85, n. 11, p. 1151, doi. 10.1111/j.1349-7006.1994.tb02921.x
- By:
- Publication type:
- Article
Phase I and Pharmacokinetic Study of Paclitaxel by 24-Hour Intravenous Infusion.
- Published in:
- Cancer Science, 1994, v. 85, n. 10, p. 1057, doi. 10.1111/j.1349-7006.1994.tb02906.x
- By:
- Publication type:
- Article
CPT-11: Population Pharmacokinetic Model and Estimation of Pharmacokinetics Using the Bayesian Method in Patients with Lung Cancer.
- Published in:
- Cancer Science, 1994, v. 85, n. 9, p. 972, doi. 10.1111/j.1349-7006.1994.tb02977.x
- By:
- Publication type:
- Article
Guidelines for Analysis and Reporting of Clinical Trials in Oncology.
- Published in:
- Cancer Science, 1993, v. 84, n. 9, p. 929, doi. 10.1111/j.1349-7006.1993.tb00180.x
- By:
- Publication type:
- Article
Basic Design Considerations for Clinical Trials in Oncology.
- Published in:
- Cancer Science, 1992, v. 83, n. 6, p. 547, doi. 10.1111/j.1349-7006.1992.tb00124.x
- By:
- Publication type:
- Article
Subcutaneous Administration of Recombinant Human Granulocyte Colony-stimulating Factor (KRN8601) in Intensive Chemotherapy for Patients with Advanced Lung Cancer.
- Published in:
- Cancer Science, 1990, v. 81, n. 11, p. 1168, doi. 10.1111/j.1349-7006.1990.tb02530.x
- By:
- Publication type:
- Article
Prediction from Creatinine Clearance of Thrombocytopenia and Recommended Dose in Patients Receiving (Glycolato-O, O′)-diammine Platinum (II) (NSC 375101D).
- Published in:
- Cancer Science, 1990, v. 81, n. 2, p. 196, doi. 10.1111/j.1349-7006.1990.tb02548.x
- By:
- Publication type:
- Article
Serial Measurement of Sister Chromatid Exchanges in the Peripheral Lymphocytes of Patients with Lung Cancer Receiving Chemotherapy in Relation to Bone Marrow Toxicity.
- Published in:
- Cancer Science, 1989, v. 80, n. 8, p. 783, doi. 10.1111/j.1349-7006.1989.tb01715.x
- By:
- Publication type:
- Article
Inhibition of Colony Formation of Drug-resistant Human Tumor Cell Lines by Combinations of Interleukin-2-activated Killer Cells and Antitumor Drugs.
- Published in:
- Cancer Science, 1989, v. 80, n. 3, p. 265, doi. 10.1111/j.1349-7006.1989.tb02303.x
- By:
- Publication type:
- Article
Three Schedules of Recombinant Human Interleukin-2 in the Treatment of Malignancy: Side Effects and Immunologic Effects in Relation to Serum Level.
- Published in:
- Cancer Science, 1988, v. 79, n. 1, p. 131, doi. 10.1111/j.1349-7006.1988.tb00020.x
- By:
- Publication type:
- Article
Congenital pulmonary veno-portal shunt.
- Published in:
- European Heart Journal - Cardiovascular Imaging, 2019, v. 20, n. 9, p. 1069, doi. 10.1093/ehjci/jez055
- By:
- Publication type:
- Article
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 11, p. 4928, doi. 10.1007/s12325-023-02648-1
- By:
- Publication type:
- Article
A phase II study of paclitaxel plus cisplatin for advanced non-small-cell lung cancer in Japanese patients.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Gender Differences in Treatment Outcomes among Patients with Non-Small Cell Lung Cancer Given a Combination of Carboplatin and Paclitaxel.
- Published in:
- Oncology, 2008, v. 75, n. 3/4, p. 169, doi. 10.1159/000159268
- By:
- Publication type:
- Article
Findings of virtual bronchoscopic navigation can predict the diagnostic rate of primary lung cancer by bronchoscopy in patients with peripheral lung lesions.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 1, p. 70, doi. 10.1007/s10147-016-1039-0
- By:
- Publication type:
- Article
Erratum to: Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Safety and pharmacokinetics of panitumumab in Japanese patients with advanced solid tumors.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 4, p. 307, doi. 10.1007/s10147-008-0855-2
- By:
- Publication type:
- Article
A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2009, v. 14, n. 2, p. 112, doi. 10.1007/s10147-008-0813-z
- By:
- Publication type:
- Article